143 related articles for article (PubMed ID: 9892315)
1. Enhancing the tolerability of tacrine with propantheline.
Faber RA; Negro PJ
Am J Psychiatry; 1999 Jan; 156(1):156. PubMed ID: 9892315
[No Abstract] [Full Text] [Related]
2. [Pharma-clinics. Drug of the month. Tacrine (Cognex)].
Scheen AJ
Rev Med Liege; 1996 May; 51(5):379-81. PubMed ID: 8992561
[No Abstract] [Full Text] [Related]
3. Alzheimer's disease.
Hier DB
Surg Neurol; 1997 Jan; 47(1):84-5. PubMed ID: 8986173
[No Abstract] [Full Text] [Related]
4. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia.
Trzepacz PT; Ho V; Mallavarapu H
Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507
[No Abstract] [Full Text] [Related]
5. What have we learned from the THA trials to facilitate testing of new AChE inhibitors.
Gauthier S; Gauthier L
Prog Brain Res; 1993; 98():427-9. PubMed ID: 8248532
[No Abstract] [Full Text] [Related]
6. Alzheimer's disease: the role of tacrine therapy.
Jogerst G
Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
[No Abstract] [Full Text] [Related]
7. [Should Alzheimer disease be treated with tacrine? Review of the literature].
Arsland D; Laake K
Tidsskr Nor Laegeforen; 1996 Sep; 116(23):2791-4. PubMed ID: 8928167
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
García-López MT; Guardado-Santervás P
Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762
[No Abstract] [Full Text] [Related]
9. Pharmacoepidemiology of tacrine in Alzheimer's disease.
Begaud B; Haramburu F; Miremont G
Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701
[No Abstract] [Full Text] [Related]
10. Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease.
Kumar V; Goldstein MZ; Doraiswamy PM
Psychiatr Serv; 1996 Mar; 47(3):249-53. PubMed ID: 8820547
[No Abstract] [Full Text] [Related]
11. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
Wallin A
Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
[No Abstract] [Full Text] [Related]
12. No association between tacrine transaminitis and the glutathione transferase theta genotype in patients with Alzheimer's disease.
De Sousa M; Pirmohamed M; Kitteringham NR; Woolf T; Park BK
Pharmacogenetics; 1998 Aug; 8(4):353-5. PubMed ID: 9731722
[No Abstract] [Full Text] [Related]
13. Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease.
Lebert F; Mouly C; Pasquier F
Age Ageing; 1998 Sep; 27(5):654. PubMed ID: 12675108
[No Abstract] [Full Text] [Related]
14. Side effects of long acting cholinesterase inhibitors.
Beermann B
Acta Neurol Scand Suppl; 1993; 149():53-4. PubMed ID: 8128840
[TBL] [Abstract][Full Text] [Related]
15. [Tacrine].
Dávila C; Viteri C; de Castro P
Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
[TBL] [Abstract][Full Text] [Related]
17. Donepezil: new preparation. Moderate efficacy in Alzheimer's disease.
Prescrire Int; 1998 Oct; 7(37):146-7. PubMed ID: 10915420
[TBL] [Abstract][Full Text] [Related]
18. [Use of cholinesterase inhibitors in Alzheimer disease].
Sampalmieri M; Troiani MP; Servi M
Clin Ter; 1993 Dec; 143(6):549-52. PubMed ID: 8306579
[TBL] [Abstract][Full Text] [Related]
19. Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease.
Bottiggi KA; Salazar JC; Yu L; Caban-Holt AM; Ryan M; Schmitt FA
Am J Geriatr Psychiatry; 2007 Apr; 15(4):357-9. PubMed ID: 17384320
[No Abstract] [Full Text] [Related]
20. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy.
Boller F; Orgogozo JM
Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
